Harbour Lab Tour: Attendees stepped inside UT Southwestern's lab to meet the scientists studying ocular melanoma. HEPZATO Demonstration: Drs. Chandrasekaran and Shannon led a closer look at liver-directed treatment for metastatic disease. Expert Medical Program: Sessions covered surveillance, biomarkers, adjuvant therapy, treatment sequencing, [...]
Researchers identified BAP1 gene abnormalities as a strong predictor of metastatic uveal melanoma. Combining BAP1 changes with chromosome 1 alterations improved the accuracy of metastasis risk prediction. The new classification system successfully separated patients into four distinct metastatic risk groups. Genetic changes linked [...]
Advocated for ocular melanoma and rare disease funding on Capitol Hill Brought together patients, families, and industry leaders for meaningful dialogue Shared real patient experiences to influence policy and awareness Strengthened community connections through planning sessions and events Built momentum for future advocacy [...]
Meet Our Team – Board Members At A Cure In Sight, every board member brings unique strength to our mission of supporting patients and funding research for ocular melanoma. Today, we are honored to warmly welcome Chris to our Board of [...]
Read full article: Delcath Systems, Inc. recently announced the publication of important subgroup analyses from its Phase 3 FOCUS study evaluating melphalan delivered via a Hepatic Delivery System in patients with unresectable metastatic uveal melanoma (mUM). Published in the Journal of [...]
Register Today: Living with ocular melanoma is about more than medical appointments and treatment plans—it’s about mental health, resilience, and learning how to move forward with confidence. On Sunday, January 25, 2026, A Cure In Sight invites patients, caregivers, and supporters [...]
Why Sponsor Eye Believe? Your sponsorship is more than a logo—it’s a lifeline. Eye Believe is one of the few nationwide events dedicated exclusively to patients living with ocular melanoma. It offers medical insight, emotional strength, and a renewed outlook on life. By partnering with us, you help ensure this event remains accessible to all, [...]
When it comes to rare cancers like ocular melanoma (OM), building awareness is essential—but often overlooked. That’s why the work of A Cure In Sight stands out as truly groundbreaking. As the only independent organization dedicated solely to ocular melanoma patients [...]
In early June, A Cure In Sight attended the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Kevin and Kristen met with oncologists from all over the world at our Exhibit, and had the ‘rare’ opportunity to meet with [...]
FOR IMMEDIATE RELEASEContact: info@acureinsight.orgWebsite: www.acureinsight.org A Cure In Sight to Exhibit at 2025 ASCO Annual Meeting in Chicago Raleigh, NC – May 2025 – A Cure In Sight (ACIS), a leading nonprofit dedicated to supporting patients with ocular melanoma, is proud to announce its participation in the 2025 [...]
